Geneva, Aug. 6 -- International Clinical Trials Registry received information related to the study (ChiCTR2600129121) titled 'Esketamine Combined with Ropivacaine for Transversus Abdominis Plane Block: Effects on Postoperative Analgesia and Postpartum Depression after Cesarean Section' on July 31.
Study Type: Interventional study
Study Design:
Parallel
Primary Sponsor: Linyi Maternal and Child Health Care Hospital
Condition:
Postpartum depression and post-operative pain in patients with cesarean section
Intervention:
Trial Group:0.125 mg/kg esketamine combined with hydrochloric acid ropivacaine 100 mg diluted to total volume 40 ml for ultrasound-guided bilateral TAP block.
Recruitment Status: Recruiting
Phase: 0
Date of First...